Optiver Holding B.V. Amgen Inc Transaction History

Optiver Holding B.V.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $129,595 - $156,437	482 New	482 $137,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $437 - $542	2 New	2 $0
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $9,651 - $10,885	43 New	43 $10,000
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $4.98 Million - $5.8 Million	22,420 New	22,420 $5.58 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

Stay updated on Optiver Holding B.V. with notifications on news.